COMPANY

Omniox

HQ: San Francisco, CA source · omniox.com ↗ · West Coast

Location: San Francisco, CA · source · Oct 14, 2026

Profile checked Oct 10, 2026

26NIH grants

Funding and NIH signals

SEC Form D raise Form D reports $24.07M in debt securities sold since 2016 (filed Mar 30, 2026). SEC Form D 0001553710-26-000004 (Mar 30, 2026)
Evidence (1 event)
- Mar 30, 2026 · SEC Form D 0001553710-26-000004
  Name of Issuer: Omniox, Inc.; CIK: 1553710; Address: San Francisco, CA; Submission type: D; Filing date: 2026-03-30; Industry Group: Other Technology; Date of First Sale: 2016-08-01; Types of Securities Offered: Debt; Business combination transaction: false; Total Offering Amount: 28063773; Total Amount Sold: 24066235; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals

Timeline

Sep 5, 2025 Grant Government grant — SBIR: $991,379 (annual award, as published), announced Sep 5, 2025. Agency: NIH/NICHD. Source: government award database. source ↗

Funding

Last 2 years.

Sep 5, 2025 Government grant — SBIR: $991,379 (annual award, as published), announced Sep 5, 2025. Agency: NIH/NICHD. Source: government award database. source ↗

NIH awards 26

Annual award amounts. Total $17.2M.

Aug 11, 2024 NIH award 5R44HD094414-06 FY2024: $995,592 awarded for that fiscal year; activity R44 (SBIR); PI WINGER, JONATHAN A; recipient as written: OMNIOX, INC., San Francisco, CA. Development of an oxygen delivery biotherape source ↗
Aug 29, 2023 NIH award 2R44HD094414-05 FY2023: $999,580 awarded for that fiscal year; activity R44 (SBIR); PI WINGER, JONATHAN A; recipient as written: OMNIOX, INC., San Francisco, CA. Development of an oxygen delivery biotherape source ↗
Apr 12, 2022 NIH award 5R01CA204723-06 FY2022: $522,676 awarded for that fiscal year; activity R01 (OTHER_NIH); PI WINGER, JONATHAN A; recipient as written: OMNIOX, INC., San Francisco, CA. Development of PET imaging biomarkers t source ↗
May 14, 2021 NIH award 5R01CA204723-05 FY2021: $538,027 awarded for that fiscal year; activity R01 (OTHER_NIH); PI WINGER, JONATHAN A; recipient as written: OMNIOX, INC., San Francisco, CA. Development of PET imaging biomarkers t source ↗
Aug 18, 2020 NIH award 5R44HD094414-04 FY2020: $232,127 awarded for that fiscal year; activity R44 (SBIR); PI WINGER, JONATHAN A; recipient as written: OMNIOX, INC., San Francisco, CA. Development of an oxygen delivery biotherape source ↗
Apr 16, 2020 NIH award 5R01CA204723-04 FY2020: supplement or administrative line (under $1,000); activity R01 (OTHER_NIH); PI KRTOLICA, ANA; recipient as written: OMNIOX, INC., San Francisco, CA. Development of PET imaging biomarkers to predict source ↗
Sep 5, 2019 NIH award 5R44HD094414-03 FY2019: $681,601 awarded for that fiscal year; activity R44 (SBIR); PI KRTOLICA, ANA; recipient as written: OMNIOX, INC., San Francisco, CA. Development of an oxygen delivery biotherapeutic source ↗
Jun 12, 2019 NIH award 5R01CA204723-03 FY2019: $546,766 awarded for that fiscal year; activity R01 (OTHER_NIH); PI KRTOLICA, ANA; recipient as written: OMNIOX, INC., San Francisco, CA. Development of PET imaging biomarkers to pre source ↗
Aug 31, 2018 NIH award 4R44HD094414-02 FY2018: $1,032,262 awarded for that fiscal year; activity R44 (SBIR); PI LE MOAN, NATACHA; recipient as written: OMNIOX, INC., San Francisco, CA. Development of an oxygen delivery biotherape source ↗
Apr 3, 2018 NIH award 5R01CA204723-02 FY2018: $585,583 awarded for that fiscal year; activity R01 (OTHER_NIH); PI KRTOLICA, ANA; recipient as written: OMNIOX, INC., San Francisco, CA. Development of PET imaging biomarkers to pre source ↗
Aug 2, 2017 NIH award 1R44HD094414-01 FY2017: $298,396 awarded for that fiscal year; activity R44 (SBIR); PI KRTOLICA, ANA; recipient as written: OMNIOX, INC., San Francisco, CA. Development of an oxygen delivery biotherapeutic source ↗
Jul 25, 2017 NIH award 5R44NS076272-03 FY2017: $1,209,149 awarded for that fiscal year; activity R44 (SBIR); PI KRTOLICA, ANA; recipient as written: OMNIOX, INC., San Francisco, CA. Reducing Brain Injury After Focal Ischemia Usin source ↗
Apr 27, 2017 NIH award 1R01CA204723-01A1 FY2017: $602,718 awarded for that fiscal year; activity R01 (OTHER_NIH); PI KRTOLICA, ANA; recipient as written: OMNIOX, INC., San Francisco, CA. Development of PET imaging biomarkers to p source ↗
Jul 28, 2016 NIH award 2R44NS076272-02A1 FY2016: $1,115,299 awarded for that fiscal year; activity R44 (SBIR); PI CARY, STEPHEN; recipient as written: OMNIOX, INC., San Francisco, CA. Reducing Brain Injury After Focal Ischemia Us source ↗
Aug 1, 2015 NIH award 1R43CA192765-01A1 FY2015: $280,141 awarded for that fiscal year; activity R43 (SBIR); PI CARY, STEPHEN; recipient as written: OMNIOX, INC., San Francisco, CA. Chemosensitizing Hypoxic Multiple Myeloma With source ↗
Sep 19, 2014 NIH award 1R43CA177097-01A1 FY2014: $225,000 awarded for that fiscal year; activity R43 (SBIR); PI CARY, STEPHEN; recipient as written: OMNIOX, INC., San Francisco, CA. Engineering of human H-NOX as an oxygen deliver source ↗
Aug 27, 2014 NIH award 5R44CA138006-07 FY2014: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI SHAH, AJIT S; recipient as written: OMNIOX, INC., San Francisco, CA. TUMOR RADIOSENSITIZATION USING A NITRIC-OXIDE-NE source ↗
Sep 17, 2013 NIH award 5R44CA138006-06 FY2013: $961,000 awarded for that fiscal year; activity R44 (SBIR); PI SHAH, AJIT S; recipient as written: OMNIOX, INC., San Francisco, CA. TUMOR RADIOSENSITIZATION USING A NITRIC-OXIDE-NEUT source ↗
Sep 26, 2012 NIH award 2R44CA138006-05 FY2012: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI SHAH, AJIT S; recipient as written: OMNIOX, INC., San Francisco, CA. TUMOR RADIOSENSITIZATION USING A NITRIC-OXIDE-NE source ↗
Sep 21, 2012 NIH award 1R43CA165629-01A1 FY2012: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI KRTOLICA, ANA; recipient as written: OMNIOX, INC., San Francisco, CA. Improving Chemotherapy with a Novel Oxygen-Deli source ↗
Jul 3, 2012 NIH award 1R43NS076272-01A1 FY2012: $274,359 awarded for that fiscal year; activity R43 (SBIR); PI CARY, STEPHEN; recipient as written: OMNIOX, INC., San Francisco, CA. Reducing Brain Injury After Focal Ischemia Usin source ↗
Mar 15, 2012 NIH award 5R44CA138006-04 FY2012: $949,265 awarded for that fiscal year; activity R44 (SBIR); PI SHAH, AJIT S; recipient as written: OMNIOX, INC., San Francisco, CA. TUMOR RADIOSENSITIZATION USING A NITRIC-OXIDE-NEUT source ↗
Feb 24, 2011 NIH award 5R44CA138006-03 FY2011: $1,494,655 awarded for that fiscal year; activity R44 (SBIR); PI SHAH, AJIT S; recipient as written: OMNIOX, INC., San Francisco, CA. TUMOR RADIOSENSITIZATION USING A NITRIC-OXIDE-NE source ↗
Sep 30, 2010 NIH award 2R44CA138006-02 FY2010: $535,024 awarded for that fiscal year; activity R44 (SBIR); PI SHAH, AJIT S; recipient as written: OMNIOX, INC., San Francisco, CA. TUMOR RADIOSENSITIZATION USING A NITRIC-OXIDE-NEUT source ↗
Jul 29, 2010 NIH award 1R43GM095125-01 FY2010: $331,743 awarded for that fiscal year; activity R43 (SBIR); PI CARY, STEPHEN; recipient as written: OMNIOX, INC., San Francisco, CA. Targeted Oxygen Delivery to Wounds: Using a Nove source ↗
Sep 25, 2008 NIH award 1R43CA138006-01 FY2008: $480,058 awarded for that fiscal year; activity R43 (SBIR); PI SHAH, AJIT S; recipient as written: OMNIOX, INC., San Francisco, CA. TUMOR RADIOSENSITIZATION USING A NITRIC-OXIDE-NEUT source ↗